[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-001", "question": "A 68-year-old man with a history of severe COPD (FEV1 35% predicted) and chronic hypercapnia (baseline PaCO2 55 mmHg) presents with acute-on-chronic hypercapnic respiratory failure requiring non-invasive ventilation. After 48 hours of improvement, his arterial blood gas shows pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg on 2 L/min nasal cannula. He is alert and comfortable. The next most appropriate step in management is:", "options": ["Gradually wean and discontinue supplemental oxygen to target a PaO2 of 55-60 mmHg", "Continue current oxygen therapy and plan for discharge home with home oxygen", "Increase oxygen flow to achieve a PaO2 > 88 mmHg", "Obtain a venous blood gas to confirm the arterial values", "Initiate acetazolamide 250 mg twice daily to accelerate renal compensation"], "answer": "A", "answer_index": 0, "explanation": "In patients with chronic hypercapnia, the hypoxic drive is a primary respiratory stimulus. Over-oxygenation can suppress this drive, leading to worsening hypercapnia and acidosis. The target PaO2 is 55-60 mmHg or SpO2 88-92%, which provides adequate oxygenation while minimizing the risk of CO2 retention. Increasing oxygen (C) is dangerous, and acetazolamide (E) is not indicated in acute-on-chronic respiratory failure as it can worsen acidosis by inhibiting compensatory metabolic alkalosis.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed).\\nVerdict on keyed answer: Miskeyed; option B is the best-supported answer, not A.\\nKey stem clues: Severe COPD with chronic hypercapnia, now improved from acute-on-chronic failure. Current ABG: pH 7.36 (near normal), PaCO2 48 mmHg (better than baseline 55), PaO2 85 mmHg on 2 L/min NC. He is alert and comfortable. These values are entirely acceptable and do not indicate dangerous over-oxygenation. A PaO2 of 85 mmHg on low-flow oxygen corresponds to an SpO2 around 95–97%, which is somewhat above the usual chronic COPD target of 88–92%, but there is no evidence of CO2 narcosis; CO2 is actually lower than baseline.\\nLogical issue: Option A (“wean and discontinue oxygen to target PaO2 55–60 mmHg”) misstates typical practice. We target SpO2 88–92% (approx PaO2 ≥60); we do not deliberately reduce PaO2 from 85 to 55–60 in a stable patient. Option B—continue current oxygen and plan for home O2—is the most reasonable disposition in a patient with severe COPD who required NIV.\\nMedical accuracy issue: Explanation overemphasizes “hypoxic drive” and uses PaO2 targets rather than SpO2, which is nonstandard.\\nMinimal fix: Change the key (and explanation) to B, and rephrase A to “titrate oxygen to maintain SpO2 88–92%” if that concept is desired as correct.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed).\nVerdict on keyed answer: Miskeyed; option B is the best-supported answer, not A.\nKey stem clues: Severe COPD with chronic hypercapnia, now improved from acute-on-chronic failure. Current ABG: pH 7.36 (near normal), PaCO2 48 mmHg (better than baseline 55), PaO2 85 mmHg on 2 L/min NC. He is alert and comfortable. These values are entirely acceptable and do not indicate dangerous over-oxygenation. A PaO2 of 85 mmHg on low-flow oxygen corresponds to an SpO2 around 95–97%, which is somewhat above the usual chronic COPD target of 88–92%, but there is no evidence of CO2 narcosis; CO2 is actually lower than baseline.\nLogical issue: Option A (“wean and discontinue oxygen to target PaO2 55–60 mmHg”) misstates typical practice. We target SpO2 88–92% (approx PaO2 ≥60); we do not deliberately reduce PaO2 from 85 to 55–60 in a stable patient. Option B—continue current oxygen and plan for home O2—is the most reasonable disposition in a patient with severe COPD who required NIV.\nMedical accuracy issue: Explanation overemphasizes “hypoxic drive” and uses PaO2 targets rather than SpO2, which is nonstandard.\nMinimal fix: Change the key (and explanation) to B, and rephrase A to “titrate oxygen to maintain SpO2 88–92%” if that concept is desired as correct.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recurrent calcium oxalate nephrolithiasis; current acute pancreatitis; serum calcium 11.8 mg/dL (elevated); PTH 85 pg/mL (inappropriately high for hypercalcemia); no lithium or thiazide use. This constellation (\\\"stones\\\" plus hypercalcemia with non-suppressed PTH) is classic for primary hyperparathyroidism, most commonly due to a parathyroid adenoma. Hypercalcemia is a recognized, though less common, cause of acute pancreatitis.\\nAlternative options: Autoimmune pancreatitis (B) would suggest obstructive jaundice, elevated IgG4, sausage-shaped pancreas with ductal narrowing, none of which are mentioned; it also does not explain hypercalcemia with elevated PTH and kidney stones. Hereditary PRSS1 pancreatitis (C) is typically earlier onset and unlinked to this biochemical profile. Hypertriglyceridemia-induced pancreatitis (D) is not supported by any triglyceride data and does not explain hypercalcemia/high PTH/stones. Gastrinoma (E) causes refractory ulcers and diarrhea; hypercalcemia in MEN1 is via concomitant hyperparathyroidism, not the gastrinoma itself.\\nMedical accuracy: The pathophysiology and association between primary hyperparathyroidism, stones, hypercalcemia, and pancreatitis are consistent with standard teaching.\\nMinimal fix: Provide PTH reference range in stem (already partially done) or explicitly note absence of other common etiologies (alcohol, gallstones) for maximal clarity, though not essential.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recurrent calcium oxalate nephrolithiasis; current acute pancreatitis; serum calcium 11.8 mg/dL (elevated); PTH 85 pg/mL (inappropriately high for hypercalcemia); no lithium or thiazide use. This constellation (\"stones\" plus hypercalcemia with non-suppressed PTH) is classic for primary hyperparathyroidism, most commonly due to a parathyroid adenoma. Hypercalcemia is a recognized, though less common, cause of acute pancreatitis.\nAlternative options: Autoimmune pancreatitis (B) would suggest obstructive jaundice, elevated IgG4, sausage-shaped pancreas with ductal narrowing, none of which are mentioned; it also does not explain hypercalcemia with elevated PTH and kidney stones. Hereditary PRSS1 pancreatitis (C) is typically earlier onset and unlinked to this biochemical profile. Hypertriglyceridemia-induced pancreatitis (D) is not supported by any triglyceride data and does not explain hypercalcemia/high PTH/stones. Gastrinoma (E) causes refractory ulcers and diarrhea; hypercalcemia in MEN1 is via concomitant hyperparathyroidism, not the gastrinoma itself.\nMedical accuracy: The pathophysiology and association between primary hyperparathyroidism, stones, hypercalcemia, and pancreatitis are consistent with standard teaching.\nMinimal fix: Provide PTH reference range in stem (already partially done) or explicitly note absence of other common etiologies (alcohol, gallstones) for maximal clarity, though not essential.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-003", "question": "A 32-year-old woman presents with 3 weeks of progressive dyspnea and fatigue. Echocardiogram shows a large pericardial effusion with diastolic right atrial and right ventricular collapse. Right heart catheterization reveals equalization of diastolic pressures (RA 18, RV 18, PA 18/20, PCWP 18 mmHg). After pericardiocentesis of 800 mL of serosanguinous fluid, hemodynamics improve. Cytology is negative. Two days later, she develops recurrent dyspnea. Repeat echo shows reaccumulation of the effusion. The most appropriate definitive management is:", "options": ["Repeat pericardiocentesis and initiate colchicine", "Surgical creation of a pericardial window via subxiphoid approach", "Initiation of high-dose prednisone for suspected autoimmune pericarditis", "Pericardiectomy via left thoracotomy", "Intrapericardial instillation of bleomycin"], "answer": "B", "answer_index": 1, "explanation": "Recurrent symptomatic pericardial effusion with tamponade physiology, especially when cytology is negative (ruling out malignancy requiring specific therapy), is a clear indication for a definitive surgical procedure to prevent reaccumulation. A surgical pericardial window (subxiphoid or video-assisted) allows for drainage and biopsy. Pericardiectomy (D) is reserved for constrictive pericarditis. Steroids (C) are for inflammatory causes but are not definitive for recurrent effusion. Intrapericardial chemotherapy (E) is for malignant effusions.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Young woman with large pericardial effusion causing tamponade (echo: RA/RV diastolic collapse; cath: equalized diastolic pressures), initial therapeutic pericardiocentesis with symptomatic improvement, then rapid reaccumulation of effusion and recurrent dyspnea within 2 days, cytology negative for malignancy. This defines recurrent, symptomatic, nonmalignant pericardial effusion after initial drainage, where a definitive surgical drainage procedure is indicated.\\nOption B (surgical pericardial window) is the standard definitive management to prevent further reaccumulation and permits ongoing drainage and tissue diagnosis. A (repeat pericardiocentesis + colchicine) is temporizing; colchicine targets pericarditis, not large recurrent effusion with tamponade physiology, and is not definitive. C (high-dose prednisone) presumes autoimmune etiology without evidence and also is not definitive for mechanical tamponade. D (pericardiectomy) is reserved mainly for constrictive pericarditis or very refractory effusions, excessive for this scenario. E (intrapericardial bleomycin) is used for malignant effusions, which are not supported given negative cytology.\\nMain medical accuracy issues: None substantive; rationale matches guideline-level practice.\\nMinimal fix: Add brief mention that repeat imaging or fluid studies have not revealed malignancy or infection to further justify nonmalignant recurrent effusion and surgical window choice.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Young woman with large pericardial effusion causing tamponade (echo: RA/RV diastolic collapse; cath: equalized diastolic pressures), initial therapeutic pericardiocentesis with symptomatic improvement, then rapid reaccumulation of effusion and recurrent dyspnea within 2 days, cytology negative for malignancy. This defines recurrent, symptomatic, nonmalignant pericardial effusion after initial drainage, where a definitive surgical drainage procedure is indicated.\nOption B (surgical pericardial window) is the standard definitive management to prevent further reaccumulation and permits ongoing drainage and tissue diagnosis. A (repeat pericardiocentesis + colchicine) is temporizing; colchicine targets pericarditis, not large recurrent effusion with tamponade physiology, and is not definitive. C (high-dose prednisone) presumes autoimmune etiology without evidence and also is not definitive for mechanical tamponade. D (pericardiectomy) is reserved mainly for constrictive pericarditis or very refractory effusions, excessive for this scenario. E (intrapericardial bleomycin) is used for malignant effusions, which are not supported given negative cytology.\nMain medical accuracy issues: None substantive; rationale matches guideline-level practice.\nMinimal fix: Add brief mention that repeat imaging or fluid studies have not revealed malignancy or infection to further justify nonmalignant recurrent effusion and surgical window choice.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 70-year-old with nonvalvular AF on apixaban; acute disabling ischemic stroke (NIHSS 15) within 4 hours; CT without hemorrhage; CTA shows left M1 MCA occlusion; explicitly stated not a candidate for IV tPA due to anticoagulation. These establish an acute large vessel occlusion in a patient ineligible for IV thrombolysis.\\nGiven current guidelines, patients with LVO and contraindication to IV tPA should undergo mechanical thrombectomy within the appropriate time window; direct thrombectomy is acceptable and now well supported by trials. Thus option B is clearly best.\\nOption A: IV tPA while therapeutically anticoagulated is contraindicated; checking INR/anti-Xa doesn’t change that in usual practice. Options C and D: reversing apixaban just to enable tPA is not guideline-supported, delays reperfusion, and increases bleeding risk. Option E: heparin drip is not indicated for acute reperfusion in ischemic stroke and does not treat LVO.\\nNo major internal contradictions or underspecification; the last-known-well is 4 hours, within the 24-hour window for thrombectomy.\\nMinimal fix: Clarify “last known well 4 hours ago” to align explicitly with mechanical thrombectomy window language, though the vignette already implies this.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 70-year-old with nonvalvular AF on apixaban; acute disabling ischemic stroke (NIHSS 15) within 4 hours; CT without hemorrhage; CTA shows left M1 MCA occlusion; explicitly stated not a candidate for IV tPA due to anticoagulation. These establish an acute large vessel occlusion in a patient ineligible for IV thrombolysis.\nGiven current guidelines, patients with LVO and contraindication to IV tPA should undergo mechanical thrombectomy within the appropriate time window; direct thrombectomy is acceptable and now well supported by trials. Thus option B is clearly best.\nOption A: IV tPA while therapeutically anticoagulated is contraindicated; checking INR/anti-Xa doesn’t change that in usual practice. Options C and D: reversing apixaban just to enable tPA is not guideline-supported, delays reperfusion, and increases bleeding risk. Option E: heparin drip is not indicated for acute reperfusion in ischemic stroke and does not treat LVO.\nNo major internal contradictions or underspecification; the last-known-well is 4 hours, within the 24-hour window for thrombectomy.\nMinimal fix: Clarify “last known well 4 hours ago” to align explicitly with mechanical thrombectomy window language, though the vignette already implies this.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-005", "question": "A 55-year-old man with alcoholic cirrhosis (Child-Pugh B) is admitted with hepatic encephalopathy. He is started on lactulose. On day 3, he develops acute kidney injury. Serum sodium is 122 mEq/L (down from 128 on admission), creatinine 2.4 mg/dL (baseline 0.9), and he is clinically envolemic. Urine sodium is <10 mEq/L, urine osmolality 550 mOsm/kg. The most likely cause of his hyponatremia is:", "options": ["Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "Acute tubular necrosis from sepsis", "Hepatorenal syndrome type 1", "Pseudohyponatremia from hypertriglyceridemia", "Hyponatremia due to lactulose-induced diarrhea"], "answer": "E", "answer_index": 4, "explanation": "Lactulose causes an osmotic diarrhea, leading to loss of sodium and water, but relatively more water loss, resulting in hypertonic hyponatremia. The clinical picture (envolemic, high urine osmolality, low urine sodium) is consistent with volume depletion from GI losses, not SIADH (which has inappropriately high urine sodium). Hepatorenal syndrome (C) is characterized by low urine sodium but typically occurs in the setting of avid sodium retention and ascites, not acute diarrhea. ATN (B) would have high urine sodium.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – the best-supported answer is E’s mechanism (volume depletion from lactulose-induced diarrhea) but option E’s wording and the explanation’s physiology are inaccurate.\\nKey stem clues: Cirrhosis with encephalopathy on lactulose, new AKI, fall in Na from 128→122, clinically hypovolemic picture (despite text saying “envolemic”), very low urine Na (<10 mEq/L) and high urine osmolality (550), which are classic for hypovolemic hyponatremia due to extrarenal losses (e.g., diarrhea). SIADH would have high urine Na; ATN would have high urine Na/low osmolality; pseudohyponatremia is not suggested; hepatorenal syndrome is usually with ascites and avid Na retention but typically causes low urine Na without overt Na loss.\\nMain logical issue(s): Among choices, the only one pointing to hypovolemic hyponatremia from GI loss is E, so the keyed mechanism is uniquely best, but the option text and provided explanation incorrectly describe the tonicity (this is hypotonic hypovolemic hyponatremia, not “hypertonic hyponatremia” with relatively more water loss).\\nMain medical accuracy issue(s): Misstatement of pathophysiology/tonicity.\\nMinimal fix: Change explanation to “loss of sodium and water with relatively more sodium than water (hypotonic, hypovolemic hyponatremia)” and correct “hypertonic” to “hypotonic.”\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – the best-supported answer is E’s mechanism (volume depletion from lactulose-induced diarrhea) but option E’s wording and the explanation’s physiology are inaccurate.\nKey stem clues: Cirrhosis with encephalopathy on lactulose, new AKI, fall in Na from 128→122, clinically hypovolemic picture (despite text saying “envolemic”), very low urine Na (<10 mEq/L) and high urine osmolality (550), which are classic for hypovolemic hyponatremia due to extrarenal losses (e.g., diarrhea). SIADH would have high urine Na; ATN would have high urine Na/low osmolality; pseudohyponatremia is not suggested; hepatorenal syndrome is usually with ascites and avid Na retention but typically causes low urine Na without overt Na loss.\nMain logical issue(s): Among choices, the only one pointing to hypovolemic hyponatremia from GI loss is E, so the keyed mechanism is uniquely best, but the option text and provided explanation incorrectly describe the tonicity (this is hypotonic hypovolemic hyponatremia, not “hypertonic hyponatremia” with relatively more water loss).\nMain medical accuracy issue(s): Misstatement of pathophysiology/tonicity.\nMinimal fix: Change explanation to “loss of sodium and water with relatively more sodium than water (hypotonic, hypovolemic hyponatremia)” and correct “hypertonic” to “hypotonic.”", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-006", "question": "A 28-year-old pregnant woman at 32 weeks gestation is admitted for severe preeclampsia with BP 170/110 mmHg. She is started on IV magnesium sulfate for seizure prophylaxis and IV labetalol for blood pressure control. One hour after initiation of magnesium, she becomes somnolent, with loss of deep tendon reflexes. Respiratory rate is 8 breaths/min. Serum magnesium level is 9.2 mg/dL. After securing the airway, the most specific immediate treatment is:", "options": ["IV administration of 10% calcium gluconate 1 gram over 10 minutes", "IV administration of furosemide 40 mg to enhance renal excretion", "Immediate hemodialysis", "Discontinuation of magnesium sulfate and administration of IV levothyroxine", "IV administration of pyridostigmine 2 mg"], "answer": "A", "answer_index": 0, "explanation": "Calcium gluconate is the direct antagonist to the life-threatening cardiac and neuromuscular effects of hypermagnesemia. It stabilizes cardiac membranes and reverses respiratory depression caused by magnesium. Furosemide (B) promotes excretion but is not immediate. Dialysis (C) is for severe cases with renal failure but is not the first step after airway management. Pyridostigmine (E) is for myasthenia, not magnesium toxicity.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 32-week pregnant patient on IV magnesium sulfate for severe preeclampsia; becomes somnolent with loss of deep tendon reflexes, respiratory rate 8/min, serum magnesium 9.2 mg/dL (toxic range). Airway has been secured already. Question asks for “most specific immediate treatment.” These findings indicate acute, symptomatic magnesium toxicity with cardiopulmonary risk.\\n\\nMechanistically, IV calcium (gluconate or chloride) is the pharmacologic antagonist to magnesium’s neuromuscular and cardiac membrane effects and is the immediate treatment once airway/breathing are addressed. Therefore option A is the single best answer.\\n\\nOption B (furosemide) can enhance magnesium excretion but is slower and adjunctive, not the most immediate specific antidotal therapy. Option C (hemodialysis) is reserved for toxicity with renal failure or refractory cases. Option D is unrelated; levothyroxine has no role. Option E (pyridostigmine) is for myasthenia gravis, not magnesium toxicity.\\n\\nNo major medical inaccuracies; the dosing and phrasing are reasonable. Minimal fix: optionally add a brief note that renal function is normal to clarify why dialysis is not preferred, though not strictly necessary for a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 32-week pregnant patient on IV magnesium sulfate for severe preeclampsia; becomes somnolent with loss of deep tendon reflexes, respiratory rate 8/min, serum magnesium 9.2 mg/dL (toxic range). Airway has been secured already. Question asks for “most specific immediate treatment.” These findings indicate acute, symptomatic magnesium toxicity with cardiopulmonary risk.\n\nMechanistically, IV calcium (gluconate or chloride) is the pharmacologic antagonist to magnesium’s neuromuscular and cardiac membrane effects and is the immediate treatment once airway/breathing are addressed. Therefore option A is the single best answer.\n\nOption B (furosemide) can enhance magnesium excretion but is slower and adjunctive, not the most immediate specific antidotal therapy. Option C (hemodialysis) is reserved for toxicity with renal failure or refractory cases. Option D is unrelated; levothyroxine has no role. Option E (pyridostigmine) is for myasthenia gravis, not magnesium toxicity.\n\nNo major medical inaccuracies; the dosing and phrasing are reasonable. Minimal fix: optionally add a brief note that renal function is normal to clarify why dialysis is not preferred, though not strictly necessary for a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-007", "question": "A 62-year-old man with a history of asbestos exposure 30 years ago presents with unilateral right-sided pleural effusion. Thoracentesis reveals exudative fluid (by Light's criteria) with cytology positive for adenocarcinoma. PET-CT shows FDG-avid right pleural thickening and effusion, with no other distant metastases. The next best step in management is:", "options": ["Systemic chemotherapy with platinum-pemetrexed", "Pleurodesis followed by systemic chemotherapy", "Extrapleural pneumonectomy", "Pleurectomy/decortication followed by adjuvant chemoradiation", "Immunotherapy with pembrolizumab as first-line treatment"], "answer": "D", "answer_index": 3, "explanation": "This describes a likely diagnosis of malignant pleural mesothelioma (given asbestos exposure, unilateral effusion, pleural thickening). For resectable disease (stage I-III) in a fit patient, the standard of care is maximal cytoreductive surgery (pleurectomy/decortication) followed by adjuvant chemotherapy and possibly radiation. Extrapleural pneumonectomy (C) is a more radical, less commonly performed option. Systemic therapy alone (A) is for unresectable disease. Pleurodesis (B) is palliative.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – option D is not the best supported answer.\\nKey stem clues: 62-year-old man, remote asbestos exposure, unilateral pleural effusion, exudate, cytology positive for adenocarcinoma, FDG-avid pleural thickening and effusion, no distant metastases. Cytology specifically says “adenocarcinoma,” which points toward metastatic pleural adenocarcinoma (most often lung, but could be other primaries), not malignant pleural mesothelioma (which is typically cytology negative or shows mesothelial cells, not adenocarcinoma).\\nLogical/medical issues: The explanation assumes malignant pleural mesothelioma, but the stem’s pathologic diagnosis contradicts this. For pleural metastasis with adenocarcinoma and no other disease, maximal cytoreductive mesothelioma surgery (D) is not standard; systemic chemotherapy (A) is the most defensible next step. Thus the clinical data support a different diagnosis and management than the keyed rationale, creating a miskey.\\nMain medical accuracy issue: Mislabeling adenocarcinoma as mesothelioma and applying mesothelioma-specific surgical management.\\nMinimal fix: Either change cytology to “malignant mesothelial cells consistent with mesothelioma” or change the key to A and modify the explanation to metastatic pleural adenocarcinoma managed with systemic therapy.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – option D is not the best supported answer.\nKey stem clues: 62-year-old man, remote asbestos exposure, unilateral pleural effusion, exudate, cytology positive for adenocarcinoma, FDG-avid pleural thickening and effusion, no distant metastases. Cytology specifically says “adenocarcinoma,” which points toward metastatic pleural adenocarcinoma (most often lung, but could be other primaries), not malignant pleural mesothelioma (which is typically cytology negative or shows mesothelial cells, not adenocarcinoma).\nLogical/medical issues: The explanation assumes malignant pleural mesothelioma, but the stem’s pathologic diagnosis contradicts this. For pleural metastasis with adenocarcinoma and no other disease, maximal cytoreductive mesothelioma surgery (D) is not standard; systemic chemotherapy (A) is the most defensible next step. Thus the clinical data support a different diagnosis and management than the keyed rationale, creating a miskey.\nMain medical accuracy issue: Mislabeling adenocarcinoma as mesothelioma and applying mesothelioma-specific surgical management.\nMinimal fix: Either change cytology to “malignant mesothelial cells consistent with mesothelioma” or change the key to A and modify the explanation to metastatic pleural adenocarcinoma managed with systemic therapy.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-008", "question": "A 40-year-old woman presents with palpitations, heat intolerance, and weight loss. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (high). Thyroid ultrasound shows a 2 cm hypoechoic nodule in the right lobe. Radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) with a photopenic area corresponding to the nodule. The most likely diagnosis is:", "options": ["Graves' disease with a coexisting cold nodule", "Toxic multinodular goiter", "Subacute thyroiditis", "Factitious thyrotoxicosis", "Marine-Lenhart syndrome (Graves' disease with a functioning nodule)"], "answer": "A", "answer_index": 0, "explanation": "The diffusely increased uptake is diagnostic of Graves' disease. The photopenic ('cold') nodule within an area of diffusely high uptake indicates a non-functioning nodule, which raises concern for malignancy and requires FNA biopsy. Marine-Lenhart syndrome (E) is Graves' with a *functioning* (hot) nodule. Toxic MNG (B) would show multiple areas of increased uptake. Subacute thyroiditis (C) shows very low uptake.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Symptomatic thyrotoxicosis (palpitations, heat intolerance, weight loss) with suppressed TSH and elevated free T4; radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) plus a photopenic area corresponding to a 2 cm hypoechoic nodule on ultrasound. Diffuse elevated uptake is characteristic of Graves’ disease; a focal photopenic area within otherwise high uptake represents a nonfunctioning, “cold” nodule coexisting with Graves.\\n\\nOption A (Graves’ disease with a coexisting cold nodule) directly matches this pattern. Option E (Marine-Lenhart syndrome) requires a functioning (hot) nodule with focal increased uptake, which contradicts the photopenic description. Toxic multinodular goiter would show patchy/multiple hot areas, not diffuse uptake. Subacute thyroiditis and factitious thyrotoxicosis would both have low/near-absent uptake, not 45% diffuse uptake.\\n\\nThere is no internal contradiction; imaging descriptions are standard and consistent with contemporary teaching. The rationale is medically accurate and the key matches the only defensible best choice.\\n\\nMinimal fix: Add a brief mention of typical Graves clinical signs (e.g., diffuse goiter, ophthalmopathy or positive TSI) to further anchor the diagnosis, though not strictly necessary for item validity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Symptomatic thyrotoxicosis (palpitations, heat intolerance, weight loss) with suppressed TSH and elevated free T4; radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) plus a photopenic area corresponding to a 2 cm hypoechoic nodule on ultrasound. Diffuse elevated uptake is characteristic of Graves’ disease; a focal photopenic area within otherwise high uptake represents a nonfunctioning, “cold” nodule coexisting with Graves.\n\nOption A (Graves’ disease with a coexisting cold nodule) directly matches this pattern. Option E (Marine-Lenhart syndrome) requires a functioning (hot) nodule with focal increased uptake, which contradicts the photopenic description. Toxic multinodular goiter would show patchy/multiple hot areas, not diffuse uptake. Subacute thyroiditis and factitious thyrotoxicosis would both have low/near-absent uptake, not 45% diffuse uptake.\n\nThere is no internal contradiction; imaging descriptions are standard and consistent with contemporary teaching. The rationale is medically accurate and the key matches the only defensible best choice.\n\nMinimal fix: Add a brief mention of typical Graves clinical signs (e.g., diffuse goiter, ophthalmopathy or positive TSI) to further anchor the diagnosis, though not strictly necessary for item validity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-009", "question": "A 50-year-old man with diabetes mellitus and hypertension is found to have a serum potassium of 6.8 mEq/L on routine labs. He is asymptomatic. ECG shows peaked T waves. He is given IV calcium gluconate, insulin/dextrose, and albuterol. His potassium decreases to 6.0 mEq/L. Renal function is normal. Further workup reveals a low serum aldosterone and elevated plasma renin activity. The most likely cause of his hyperkalemia is:", "options": ["Type 4 renal tubular acidosis (hyporeninemic hypoaldosteronism)", "Addison's disease", "Gordon's syndrome (pseudohypoaldosteronism type II)", "Spironolactone use", "Rhabdomyolysis"], "answer": "C", "answer_index": 2, "explanation": "Gordon's syndrome (familial hyperkalemic hypertension) is characterized by hyperkalemia, hypertension, normal GFR, metabolic acidosis, and *suppressed* renin but *normal or high* aldosterone. The key here is the elevated renin, which rules out hyporeninemic hypoaldosteronism (A, which has low renin and low aldosterone) and points to a primary renal defect in potassium excretion. Addison's (B) has low aldosterone and high renin but also has hyponatremia and hypotension.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – best supported option is B, not C.\\n\\nKey stem clues: 50-year-old man with diabetes and hypertension, severe hyperkalemia, normal renal function, and on workup has low aldosterone with *elevated* plasma renin activity. The question asks for the most likely cause of hyperkalemia.\\n\\nLow aldosterone with high renin indicates primary adrenal insufficiency or isolated hypoaldosteronism of adrenal origin, not Gordon’s syndrome. Gordon’s syndrome is characterized by hyperkalemia, hypertension, **suppressed renin**, and normal or high aldosterone; the stem’s renin/aldosterone pattern explicitly contradicts this, so C is incompatible.\\n\\nType 4 RTA (A) is typically hyporeninemic hypoaldosteronism (low renin, low aldosterone), so the elevated renin makes A less consistent. Spironolactone (D) and rhabdomyolysis (E) would not explain low aldosterone with high renin as a primary endocrine pattern. Addison’s disease (B) classically has low aldosterone with high renin, matching the given labs and being the single best fit among choices.\\n\\nMinimal fix: Change the keyed correct answer from C to B, or alter the laboratory description to “low renin, normal/high aldosterone” if Gordon’s syndrome is intended.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – best supported option is B, not C.\n\nKey stem clues: 50-year-old man with diabetes and hypertension, severe hyperkalemia, normal renal function, and on workup has low aldosterone with *elevated* plasma renin activity. The question asks for the most likely cause of hyperkalemia.\n\nLow aldosterone with high renin indicates primary adrenal insufficiency or isolated hypoaldosteronism of adrenal origin, not Gordon’s syndrome. Gordon’s syndrome is characterized by hyperkalemia, hypertension, **suppressed renin**, and normal or high aldosterone; the stem’s renin/aldosterone pattern explicitly contradicts this, so C is incompatible.\n\nType 4 RTA (A) is typically hyporeninemic hypoaldosteronism (low renin, low aldosterone), so the elevated renin makes A less consistent. Spironolactone (D) and rhabdomyolysis (E) would not explain low aldosterone with high renin as a primary endocrine pattern. Addison’s disease (B) classically has low aldosterone with high renin, matching the given labs and being the single best fit among choices.\n\nMinimal fix: Change the keyed correct answer from C to B, or alter the laboratory description to “low renin, normal/high aldosterone” if Gordon’s syndrome is intended.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-010", "question": "A 65-year-old man with a mechanical aortic valve (On-X) on warfarin presents with a transient ischemic attack. INR on presentation is 1.8 (target 2.5-3.5). He has no bleeding history. The most appropriate adjustment to his antithrombotic regimen is:", "options": ["Increase warfarin dose to achieve INR 2.5-3.5; add aspirin 81 mg daily", "Increase warfarin dose to achieve INR 2.5-3.5; no aspirin needed", "Switch to apixaban 5 mg twice daily", "Add clopidogrel 75 mg daily to current warfarin therapy", "Discontinue warfarin and initiate dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "A", "answer_index": 0, "explanation": "For a mechanical aortic valve, the standard of care is warfarin with a target INR of 2.5-3.5. In patients who have a thromboembolic event despite therapeutic INR, adding aspirin 75-100 mg is recommended. Since his INR was subtherapeutic at the time of the TIA, the first step is to optimize INR control. However, given the event, adding low-dose aspirin is now indicated based on PROACT and other trials. Direct oral anticoagulants (C) are contraindicated in mechanical valves. Dual antiplatelet therapy (E) is inferior to warfarin for valve protection.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 65-year-old man, mechanical aortic valve (On‑X), on warfarin, has TIA, INR 1.8 with stated target 2.5–3.5, no bleeding history, question asks for adjustment of antithrombotic regimen. Guideline-based management of a thromboembolic event in a mechanical valve patient is to ensure therapeutic VKA and add low‑dose aspirin if no significant bleeding risk. Here, INR is subtherapeutic, so warfarin intensity must be optimized; in addition, given a clinical thromboembolic event and absence of bleeding history, adding aspirin is indicated. Thus option A (raise INR to target and add aspirin 81 mg) is the best choice.\\nOption B fails to address the thromboembolic event by omitting aspirin. C (apixaban) is contraindicated in mechanical valves. D (add clopidogrel alone) is not guideline‑recommended and doesn’t correct INR. E (stop warfarin and use DAPT) is inferior and unsafe.\\nMain medical issue: minor nuance—On‑X valves may have lower INR targets in some protocols, but the item states the target, which can be accepted for exam purposes.\\nMinimal fix: Clarify that this patient has no contraindication to aspirin (e.g., “no history of GI bleeding or aspirin intolerance”).\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 65-year-old man, mechanical aortic valve (On‑X), on warfarin, has TIA, INR 1.8 with stated target 2.5–3.5, no bleeding history, question asks for adjustment of antithrombotic regimen. Guideline-based management of a thromboembolic event in a mechanical valve patient is to ensure therapeutic VKA and add low‑dose aspirin if no significant bleeding risk. Here, INR is subtherapeutic, so warfarin intensity must be optimized; in addition, given a clinical thromboembolic event and absence of bleeding history, adding aspirin is indicated. Thus option A (raise INR to target and add aspirin 81 mg) is the best choice.\nOption B fails to address the thromboembolic event by omitting aspirin. C (apixaban) is contraindicated in mechanical valves. D (add clopidogrel alone) is not guideline‑recommended and doesn’t correct INR. E (stop warfarin and use DAPT) is inferior and unsafe.\nMain medical issue: minor nuance—On‑X valves may have lower INR targets in some protocols, but the item states the target, which can be accepted for exam purposes.\nMinimal fix: Clarify that this patient has no contraindication to aspirin (e.g., “no history of GI bleeding or aspirin intolerance”).", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]